Theranica Ltd, a digital therapeutics company developing advanced neuromodulation devices for migraines and other pain, announced this week it received expanded clearance from US regulators to market its wearable Nerivio as a preventive treatment for migraines.
The arm-worn device has previously been cleared by the US Food and Drug Administration for acute treatment of migraine in the same patient group. Theranica expects Nerivio to be an...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?